CLINICAL_TRIALS
trial_result
· 2013-10-21
Clinical Trial Update: AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis [Phase 3]
Summary
A Phase 3 trial evaluating an anticoagulant in idiopathic pulmonary fibrosis was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Duke University | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: TERMINATED | Results posted: 2013-10-21